FN Clarivate Analytics Web of Science
VR 1.0
PT J
DE magnetic resonance imaging; molecular imaging; nanoprobes; optical
   imaging; self-assembly
ID AGGREGATION-INDUCED EMISSION; IN-VIVO; MULTIFUNCTIONAL NANOPARTICLES;
   F-19 NANOPARTICLES; GOLD NANOPARTICLES; CELL APOPTOSIS; DRUG-DELIVERY;
   NANOTECHNOLOGY; PROBES; VITRO
ER

PT J
DE Molecular; Imaging; Infective; Endocarditis; Diagnosis
ID CARDIAC DEVICE INFECTION; ENDOCARDITIS; DIAGNOSIS; PET
ER

PT J
DE Atherosclerosis; Vulnerable plaque imaging; Translational medicine;
   Molecular imaging
ID HIGH-RISK PATIENTS; PCSK9 INHIBITORS; ATHEROSCLEROSIS; INFLAMMATION;
   RATIONALE; EVENTS; DESIGN; PET
ER

PT J
DE Deep learning; Molecular imaging; Machine learning; Convolutional neural
   network; Precision medicine
ID CONVOLUTIONAL NEURAL-NETWORKS; BRAIN-TUMOR SEGMENTATION; IMAGES; CANCER;
   MRI; VOLUME; PET/CT; MODEL
ER

PT J
DE In vivo imaging; nuclear imaging; optical imaging; precision medicine
ID NICOTINIC ACETYLCHOLINE-RECEPTORS; POSITRON-EMISSION-TOMOGRAPHY;
   BREAST-CANCER XENOGRAFTS; MEMBRANE ANTIGEN; INTRAOPERATIVE
   VISUALIZATION; ATHEROSCLEROTIC PLAQUES; ALZHEIMERS-DISEASE; PD-L1
   EXPRESSION; RATIONAL DESIGN; PROSTATE-CANCER
ER

PT J
DE Molecular imaging; Pulmonary disease; SPECT; PET
ID ISCHEMIA-REPERFUSION INJURY; RESPIRATORY-DISTRESS-SYNDROME; CELL
   LUNG-CANCER; TUMOR-METASTASIS; LYMPHATIC VASCULATURE; INTERNATIONAL
   SOCIETY; INFECTION; PET; TRANSPLANTATION; INFLAMMATION
ER

PT J
DE Molecular imaging; Small molecule-based probes; UPAR; AE105; NIR-II;
   Multimodal imaging
ID PLASMINOGEN-ACTIVATOR RECEPTOR; NEAR-INFRARED WINDOW; IN-VIVO; UROKINASE
   RECEPTOR; FLUORESCENCE; EXPRESSION; PET; FLUOROPHORES; CONSTRUCTION;
   DISCOVERY
ER

PT J
DE molecular imaging; imaging probe; nuclear medical imaging;
   radiotheranostic; optical imaging; photoacoustic imaging
ID TYPE-1 MATRIX-METALLOPROTEINASE; NICOTINIC ACETYLCHOLINE-RECEPTORS;
   POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE BRAINS; NOREPINEPHRINE
   TRANSPORTER DENSITY; INDUCIBLE FACTOR-1-ACTIVE REGIONS; ANTI-HER2
   FRAGMENT ANTIBODY; PLAQUE INSTABILITY-ANALYSIS; IRON-OXIDE
   NANOPARTICLES; METASTATIC BONE PAIN
ER

PT J
DE lymphoma; molecular imaging; drugs; PET-CT; bioluminescence
ID POSITRON-EMISSION-TOMOGRAPHY; NON-HODGKINS-LYMPHOMA; B-CELL LYMPHOMA;
   SODIUM-IODIDE SYMPORTER; IN-VIVO; REPORTER GENE; BRENTUXIMAB VEDOTIN;
   FLUORESCENT PROTEINS; CANCER STATISTICS; NUCLEAR-MEDICINE
ER

PT J
DE molecular imaging; atherosclerosis; near infrared; fluorescence; PET;
   venous thromboembolism
ID DEEP-VEIN THROMBOSIS; FDG-PET/CT; ARTERIAL INFLAMMATION;
   PULMONARY-EMBOLISM; IN-VIVO; PLAQUE INFLAMMATION; F-18-FDG UPTAKE;
   CAROTID-ARTERY; RISK; EVENTS
ER

PT J
DE Molecular imaging; Laboratory management; World Molecular Imaging
   Society
ID SMALL ANIMALS; ANESTHESIA
ER

PT J
DE Molecular imaging; Drug research and development; Positron emission
   tomography; Imaging biomarkers
ID MODERATE ALZHEIMERS-DISEASE; CENTRAL-NERVOUS-SYSTEM; NEUROFIBRILLARY
   TANGLES; RECEPTOR ANTAGONIST; TAU; APREPITANT; TRIALS; BIOMARKERS;
   DIAGNOSIS; SEVERITY
ER

PT J
DE editorial; energy metabolism; cancer metabolic reprogramming; molecular
   imaging; imaging methods
ID MALIGNANT-TRANSFORMATION; PHOSPHOLIPID-METABOLISM; CELLS; INHIBITION;
   MEMBRANE
ER

PT J
ER

PT J
DE Molecular imaging; Molecular imaging probes; Cardiovascular disease
ID MAGNETIC-RESONANCE DETECTION; IN-VIVO; MYOCARDIAL-INFARCTION;
   MITOCHONDRIAL-MEMBRANE; IRON-OXIDE; ATHEROSCLEROTIC LESIONS; NONINVASIVE
   ASSESSMENT; GOLD NANOPARTICLES; RAT MODEL; TOMOGRAPHY
ER

PT J
ID CONVOLUTIONAL NEURAL-NETWORKS; BRAIN-TUMOR SEGMENTATION;
   PROSTATE-CANCER; PET/CT IMAGES; DIMENSIONALITY; REPRESENTATION;
   REDUCTION
ER

PT J
ER

PT J
DE Atherosclerosis; Molecular imaging; Positron emission tomography;
   Near-infrared fluorescence; Optical coherence tomography
ID POSITRON-EMISSION-TOMOGRAPHY; CAROTID PLAQUE INFLAMMATION; ACUTE
   CORONARY SYNDROME; ULTRASMALL SUPERPARAMAGNETIC PARTICLES; ACUTE
   MYOCARDIAL-INFARCTION; IN-VIVO; RISK-FACTORS; IRON-OXIDE; FDG-PET/CT;
   GA-68-DOTATATE PET/CT
ER

PT J
DE nanoparticles; medical imaging; molecular imaging; nanoparticle; imaging
   and diagnostics
ID LYMPH-NODE BIOPSY; INDOCYANINE GREEN; BREAST-CANCER; TC-99M; DIAGNOSIS;
   THERAPY
ER

PT J
DE Molecular imaging; instrumentation SPECT; instrumentation PET; optical
   imaging
ER

PT J
DE Molecular imaging; Molecular targeting; Brain tumor; Liposomes; Iron
   oxide nanoparticle; Gold nanoparticle
ID SUPERPARAMAGNETIC IRON-OXIDE; CONVECTION-ENHANCED DELIVERY;
   MAGNETIC-RESONANCE ANGIOGRAPHY; POSITRON-EMISSION-TOMOGRAPHY;
   NEUTRON-CAPTURE THERAPY; PH-SENSITIVE LIPOSOMES; NUCLEIC-ACID TARGETS;
   RAT GLIOMA MODEL; IN-VIVO TRACKING; DRUG-DELIVERY
ER

PT J
DE Multimodal imaging; Molecular imaging; Molecular probe; Nanomaterial;
   Gene reporter; Tumor; Review
ID GA-68-LABELED PSMA LIGAND; RECURRENT PROSTATE-CANCER; IN-VIVO;
   MAGNETIC-RESONANCE; CONTRAST AGENTS; REPORTER-GENE; COMPUTED-TOMOGRAPHY;
   LIVING SUBJECTS; PET/CT; NANOPARTICLES
ER

PT J
DE Molecular imaging; basic science; diagnostic and prognostic application
ID CLINICAL TRANSLATION
ER

PT J
DE molecular imaging; cancer; interventional oncology; biopsy; ablation;
   interventional radiology; PET/CT; fluorescence imaging
ID GUIDED PERCUTANEOUS BIOPSY; PRIOR PET/CT IMAGES; RADIOFREQUENCY
   ABLATION; LIVER METASTASES; EXPERIENCE; MEDICINE; THERAPY; LESIONS;
   CANCER; REGISTRATION
ER

PT J
DE molecular imaging; radioactive probe; positron emission tomography;
   single-photon emission computed tomography; nicotinic acetylcholine
   receptor; hypoxia-inducible factor-1
ID NICOTINIC ACETYLCHOLINE-RECEPTORS; INDUCIBLE FACTOR-1-ACTIVE REGIONS;
   CHOLINERGIC-RECEPTORS; COMPUTED-TOMOGRAPHY; HYPOXIA; BRAIN; SPECT;
   LIGAND; TUMOR; QUANTIFICATION
ER

PT J
DE molecular; imaging; genetic; reporter gene; medicine; optical
ER

PT J
ER

PT J
DE Breast cancer; PET; Molecular imaging; Molecular target therapy; HER2
ID POSITRON-EMISSION-TOMOGRAPHY; ESTROGEN-RECEPTOR; FDG-PET; NEOADJUVANT
   CHEMOTHERAPY; WHOLE-BODY; CU-64-DOTA-TRASTUZUMAB PET; ADJUVANT
   CHEMOTHERAPY; F-18-FDG PET; THERAPY; TRASTUZUMAB
ER

PT J
DE Click reaction; F-18; CuAAC; Molecular imaging; Pretargeting
ER

PT J
DE optical molecular imaging; multimodality molecular imaging; optical
   multimodality tomography; Cerenkov luminescence imaging; intraoperative
   image-guided surgery
ER

PT J
DE bioresponsive agents; activatable probes; molecular imaging; biomarker
ID CELL-PENETRATING PEPTIDES; NEAR-INFRARED-FLUORESCENCE; MRI CONTRAST
   AGENT; POSITRON-EMISSION-TOMOGRAPHY; MATRIX-METALLOPROTEINASE ACTIVITY;
   INDUCED MAGNETIZATION ENHANCEMENT; FIBROBLAST ACTIVATION PROTEIN;
   BETA-GALACTOSIDASE ACTIVITY; HYDROGEN-PEROXIDE; LIVING CELLS
ER

PT J
ER

PT J
ER

PT S
DE microbubble; targeted imaging; angiogenesis; microvasculature; biomarker
ID IMPROVING SENSITIVITY; SIZE DISTRIBUTION; CONTRAST AGENTS
ER

PT J
DE Tumor metastasis; Molecular imaging; MRI; Optical Imaging; PET;
   Nanoparticles
ID SOLUBLE MAGNETITE NANOCRYSTALS; LYMPH-NODE METASTASES; ONE-POT REACTION;
   IN-VIVO; PROSTATE-CANCER; CLINICAL-APPLICATIONS; COMPUTED-TOMOGRAPHY;
   RESONANCE DETECTION; GASTRIC-CANCER; IRON-OXIDE
ER

PT J
DE Optical molecular imaging; targeted drug delivery; bioluminescence
   imaging; fluorescence imaging; two-photon microscopy; Raman imaging
ID RAMAN-SCATTERING MICROSCOPY; MESENCHYMAL STEM-CELLS; IN-VIVO;
   BIOLUMINESCENCE TOMOGRAPHY; 2-PHOTON MICROSCOPY; LIVING CELLS;
   MOUSE-BRAIN; NANOPARTICLES; FLUORESCENCE; THERAPY
ER

PT J
DE Molecular imaging; Individualized medicine; Receptor; Angiogenesis;
   Apoptosis
ER

PT J
DE Atherosclerosis; Vulnerable plaque; Molecular imaging; Nuclear molecular
   imaging; CT; MRI
ID POSITRON-EMISSION-TOMOGRAPHY; CELL-ADHESION MOLECULE-1;
   CORONARY-ARTERY-DISEASE; MACROPHAGES IN-VIVO; MAGNETIC-RESONANCE;
   ATHEROSCLEROTIC PLAQUES; CARDIOVASCULAR-DISEASE; CONTRAST AGENT;
   IRON-OXIDE; F-18 FLUORODEOXYGLUCOSE
ER

PT J
DE molecular imaging; drug delivery system; theragnostics; tumor;
   nanomedicine
ID CHITOSAN NANOPARTICLES; COPOLYMERS; N-(2-HYDROXYPROPYL)METHACRYLAMIDE;
   VASCULATURE; THERAPY; PEPTIDE
ER

PT J
DE skin biopsy; molecular hyperspectral imaging; skin histopathology; image
   processing; skin morphology; visualization enhancement
ID SECTIONS
ER

PT J
DE molecular imaging; ophthalmology; ophthalmic imaging; eye; optical
   imaging; optical coherence tomography; magnetic resonance imaging;
   multispectral imaging; scanning laser ophthalmoscope
ID OPTICAL COHERENCE TOMOGRAPHY; RETINAL GANGLION-CELLS; INDOCYANINE-GREEN
   ANGIOGRAPHY; INDEPENDENT PHOTORECEPTOR APOPTOSIS; SCANNING LASER
   OPHTHALMOSCOPY; CONFOCAL NEUROIMAGING ICON; TRANSGENIC MOUSE MODEL;
   IN-VIVO VISUALIZATION; AMYLOID-BETA DEPOSITS; NITRIC-OXIDE SYNTHASE
ER

PT J
DE breast; breast tumors; molecular imaging; MRI; MR spectroscopy; nuclear
   imaging; radiotracers
ID POSITRON-EMISSION MAMMOGRAPHY; PROTON MR SPECTROSCOPY;
   MAGNETIC-RESONANCE; FDG-PET; DIAGNOSTIC-ACCURACY; IN-VIVO; PRONE
   SCINTIMAMMOGRAPHY; F-18 FLUORODEOXYGLUCOSE; DIFFERENTIAL-DIAGNOSIS;
   CLINICAL-APPLICATIONS
ER

PT J
DE optical imaging; fluorescence imaging; image processing; intraoperative
   imaging
ID CANCER
ER

PT J
DE Breast tumor; Magnetic resonance imaging (MRI); Nuclear imaging; MR
   spectroscopy; Radiotracers
ID POSITRON-EMISSION-TOMOGRAPHY; C-13 MAGNETIC-RESONANCE; CONTRAST-ENHANCED
   MRI; HYPERPOLARIZED C-13; IN-VIVO; F-18-FDG PET; CANCER-PATIENTS;
   FDG-PET; 3 T; CU-64-DOTA-TRASTUZUMAB PET
ER

PT J
DE aptamers; molecular imaging probes; molecular diagnostics; aptamer
ID NUCLEIC-ACID APTAMERS; CONTRAST AGENTS; MICROBUBBLES; THROMBIN
ER

PT J
DE molecular imaging; oncology; breast; PET; PET/CT; radiopharmaceuticals;
   breast cancer; breast-specific gamma imaging; positron-emission
   mammography; positron-emission tomography
ID POSITRON EMISSION MAMMOGRAPHY; NEOADJUVANT CHEMOTHERAPY; CANCER;
   METAANALYSIS; WOMEN; PREDICTION; DIAGNOSIS; ACCURACY; THERAPY; MRI
ER

PT J
ID PROTEIN-PROTEIN INTERACTIONS; NEAR-INFRARED FLUORESCENCE; TRANSGENIC
   MOUSE MODEL; FACTOR-KAPPA-B; IN-VIVO; LIVING MICE; GENE-EXPRESSION;
   BREAST-CANCER; LUCIFERASE REPORTER; RENILLA LUCIFERASE
ER

PT J
DE correlative imaging; molecular imaging; oncology; PET; PET/CT; PET/MRI;
   radiopharmaceuticals; cancer; imaging; molecular; prostate
ID ANTI-1-AMINO-3-F-18-FLUOROCYCLOBUTANE-1-CARBOXYLIC ACID; BIOCHEMICAL
   RECURRENCE; MEMBRANE ANTIGEN; F-18-FDG PET/CT; TOMOGRAPHY; CARCINOMA
ER

PT J
DE bone; cancer; cartilage; chondrocyte; fracture; imaging; infection;
   inflammation; muscle; osteoarthritis; osteoblast; osteoclast; pain;
   rheumatoid arthritis; stem cells
ID MESENCHYMAL STEM-CELLS; POSITRON-EMISSION-TOMOGRAPHY; NEAR-INFRARED
   FLUORESCENCE; COLLAGEN-INDUCED ARTHRITIS; IN-VIVO; MAGNETIC-RESONANCE;
   NEUROPATHIC PAIN; RHEUMATOID-ARTHRITIS; MOUSE MODEL; RADIOFLUORINATED
   PYRIMIDINE-2,4,6-TRIONES
ER

PT J
DE molecular imaging; oncology; PET; gene therapy; reporter gene imaging
ID POSITRON-EMISSION-TOMOGRAPHY; HUMAN NOREPINEPHRINE TRANSPORTER; IN-VIVO;
   THYMIDINE KINASE; TRANSGENIC MICE; CELL THERAPY; LIVING ANIMALS;
   EXPRESSION; RECEPTOR; PET
ER

PT S
DE small animal molecular imaging; imaging cassette; co-registration;
   multimodal imaging
ER

PT J
ER

PT J
ER

PT J
DE angiogenesis; contrast agents; inflammation; microbubbles; molecular
   imaging; ultrasound
ID ACOUSTIC RADIATION FORCE; TUMOR-ANGIOGENESIS; P-SELECTIN; IN-VITRO;
   SHEAR-FLOW; POLY(ETHYLENE GLYCOL); ACTIVATED LEUKOCYTES; ENHANCED
   ULTRASOUND; ADHESION MOLECULE-1; TARGETED DELIVERY
ER

PT J
ER

PT J
ER

PT J
DE Fusion reporters; molecular imaging
ID REPORTER GENE-EXPRESSION; XENOGRAFTS; MICE
ER

PT J
ER

PT J
DE Molecular imaging; Animal model; Imaging informatics; Data Grid
ID INFORMATICS; MANAGEMENT
ER

PT J
DE Molecular imaging; Breast cancer; PET-MRI; Multiparametric MRI; Nuclear
   imaging
ID PROTON MR SPECTROSCOPY; POSITRON-EMISSION MAMMOGRAPHY; CONTRAST-ENHANCED
   MRI; TC-99M SESTAMIBI SCINTIMAMMOGRAPHY; REPERFUSED
   MYOCARDIAL-INFARCTION; TISSUE SODIUM CONCENTRATION;
   NUCLEAR-MAGNETIC-RESONANCE; POSITIVE PREDICTIVE-VALUE;
   DIFFUSION-WEIGHTED MRI; IN-VIVO
ER

PT J
DE Integrin; molecular imaging; molecular therapy; theranostics
ER

PT J
DE atherosclerosis; heart failure; molecular imaging; myocardial
   infarction; thrombosis
ID POSITRON-EMISSION-TOMOGRAPHY; RABBIT ATHEROSCLEROTIC PLAQUES; CARDIAC
   MAGNETIC-RESONANCE; ACUTE CORONARY SYNDROMES; IN-VIVO; STEM-CELLS;
   MYOCARDIAL-INFARCTION; CONTRAST AGENT; MATRIX METALLOPROTEINASES; ACTIVE
   INFLAMMATION
ER

PT J
DE Tumor; receptor; molecular imaging; dual-targeted; peptide heterodimer
ID POSITRON-EMITTING RADIOTRACERS; RGD-BOMBESIN HETERODIMER; GROWTH-FACTOR
   RECEPTOR; PEPTIDE-BASED PROBES; TUMOR ANGIOGENESIS; PROSTATE-CANCER;
   IN-VIVO; NEUROENDOCRINE TUMORS; BISPECIFIC ANTIBODIES; MULTIMERIC
   LIGANDS
ER

PT J
DE Optical molecular imaging; planar imaging; tomographic imaging;
   bioluminescence tomography; fluorescence molecular tomography;
   multimodality fusion
ID RESOLVED BIOLUMINESCENCE TOMOGRAPHY; IN-VIVO; FLUORESCENCE TOMOGRAPHY;
   RECONSTRUCTION METHOD; COMPUTED-TOMOGRAPHY; TIME-DOMAIN; LIGHT; MICE;
   SIMULATION; MODALITY
ER

PT J
DE Molecular imaging; imaging probe design; imaging probe development
   strategies
ID POSITRON-EMISSION-TOMOGRAPHY; STIMULATING HORMONE ANALOG; SMALL-ANIMAL
   PET; INTEGRIN ALPHA(V)BETA(3) EXPRESSION; PROTEIN-SYNTHESIS RATE;
   IN-VIVO; CLICK CHEMISTRY; TUMOR XENOGRAFTS; LIVING SUBJECTS; PROTEOMIC
   TECHNOLOGIES
ER

PT J
ID POSITRON-EMISSION-TOMOGRAPHY; CONTRAST-ENHANCED ULTRASOUND;
   MAGNETIC-RESONANCE-SPECTROSCOPY; NONINVASIVE RAMAN-SPECTROSCOPY; OPTICAL
   COHERENCE TOMOGRAPHY; PROTON MR SPECTROSCOPY; IN-VIVO PATHOLOGY; TUMOR
   ANGIOGENESIS; PROSTATE-CANCER; LIVING MICE
ER

PT J
DE molecular imaging; multimodality cardiovascular molecular imaging
ER

PT J
DE molecular imaging; cardiovascular; multidisciplinary approach
ID OPTICAL COHERENCE TOMOGRAPHY; ACUTE MYOCARDIAL-INFARCTION; ACUTE
   CORONARY SYNDROME; MESENCHYMAL STEM-CELLS; MONOCYTE CHEMOATTRACTANT
   PROTEIN-1; STABLE ANGINA-PECTORIS; ATHEROSCLEROTIC PLAQUES; VULNERABLE
   PLAQUE; LESION MORPHOLOGY; PROGNOSTIC VALUE
ER

PT J
DE Molecular imaging; Nanotechnology; Quantum dots; Indirect imaging;
   Optical imaging; Positron emission tomography
ID POSITRON-EMISSION-TOMOGRAPHY; REPORTER GENE-EXPRESSION; IN-VIVO;
   TRANSGENE EXPRESSION; SODIUM/IODIDE SYMPORTER; TRANSFERRIN RECEPTOR;
   DEPRESSED-PATIENTS; LIVING ANIMALS; QUANTUM DOTS; DRUG-NAIVE
ER

PT J
ER

PT J
DE molecular imaging; stroke; optical imaging
ID TISSUE-PLASMINOGEN ACTIVATOR; ACUTE ISCHEMIC-STROKE; CEREBRAL-ARTERY
   INFARCTION; CAROTID-ARTERY; IN-VIVO; REAL-TIME; HEMORRHAGIC
   TRANSFORMATION; ATHEROSCLEROTIC LESIONS; CARDIOVASCULAR-DISEASE;
   NONINVASIVE DETECTION
ER

PT J
ID OPTICAL COHERENCE TOMOGRAPHY; IN-VIVO; GENE-EXPRESSION; FEASIBILITY;
   DELIVERY; CANCER; SYSTEM
ER

PT J
ER

PT J
DE Angiogenesis; Apoptosis; Blood flow; Brain; Computed tomography (CT);
   Cardiomyopathy; Movement disorder; Receptor; Metabolism; Magnetic
   resonance imaging (MRI); Magnetic resonance spectroscopy (MRS); Magnetic
   resonance spectroscopy imaging (MRSI); Optical imaging perfusion;
   Positron emission tomography (PET); Single photon emission computed;
   tomography (SPECT); Ultrasound; Humans; Trials; Criteria
ID POSITRON-EMISSION-TOMOGRAPHY; TUMOR PROLIFERATIVE ACTIVITY;
   BREAST-CANCER; PROSTATE-CANCER; NEUROENDOCRINE TUMORS;
   INITIAL-EXPERIENCE; PARKINSONS-DISEASE; GLUCOSE-METABOLISM;
   MALIGNANT-TUMORS; DRUG DEVELOPMENT
ER

PT B
DE molecular imaging; vivo imaging; nano-molecular probe; target tropism
ID NANOPARTICLES; RELEASE; DRUG
ER

PT B
DE Molecular imaging; radiation force; monodisperse contrast agents;
   targeted imaging
ID ACOUSTIC RADIATION FORCE; CONTRAST AGENTS; MICROBUBBLES
ER

PT S
DE optical coherence tomography (OCT); fluorescence molecular imaging (FMI)
ER

PT J
ER

PT J
DE cardiovascular diseases; diagnosis; imaging; radionuclide imaging; image
   three-dimensional; molecular probes
ID POSITRON-EMISSION-TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY;
   INTERCELLULAR-ADHESION MOLECULE-1; ULTRASOUND CONTRAST AGENTS; REPORTER
   GENE-EXPRESSION; SMALL-ANIMAL PET; INTRAVASCULAR ULTRASOUND;
   TIME-COURSE; IRON-OXIDE; MICROBUBBLES
ER

PT J
ER

PT J
ID OPTICAL-SIMULATION ENVIRONMENT; FINITE-ELEMENT ALGORITHM;
   BIOLUMINESCENCE TOMOGRAPHY; GENE-EXPRESSION; RECONSTRUCTION; PROBES;
   LIGHT; MODEL; MICE
ER

PT J
DE molecular imaging; imaging probe discovery; HTS
ID CHEMICAL GENETICS; DRUG DISCOVERY; ZEBRAFISH; ANGIOGENESIS; LIBRARY;
   ASSAY
ER

PT J
DE Molecular imaging; mu PET; Mouse models; AD
ER

PT S
DE Optical activity; metabolic imaging; molecular contrast agents and
   biomarkers; enhanced target detection techniques; Stokes parameters
   imaging
ID MUELLER MATRIX; TISSUES; POLARIZATION; SCATTERING; SYSTEM
ER

PT J
ID POSITRON-EMISSION-TOMOGRAPHY; RECEPTOR TYROSINE KINASES; SODIUM-IODIDE
   SYMPORTER; SMALL-ANIMAL PET; IN-VIVO; GENE-THERAPY; TUMOR ANGIOGENESIS;
   CONTRAST AGENTS; HEAT-SHOCK; INTEGRIN ALPHA(V)BETA(3)
ER

PT B
DE Bioendoscopy; Molecular imaging; Narrow-band imaging; Autofluorescence
   imaging; Near-infrared optical imaging
ID GASTRIC-CANCER; MAGNIFYING ENDOSCOPE; SYSTEM; ANTIBODY; TUMORS
ER

PT J
DE cancer; molecular imaging; nanomedicine; nanoplatforms; nanotechnology
ID SUPERPARAMAGNETIC IRON-OXIDE; ULTRASOUND CONTRAST AGENTS; SEMICONDUCTOR
   QUANTUM DOTS; COMPUTED-TOMOGRAPHY LYMPHOGRAPHY; OPTICAL COHERENCE
   TOMOGRAPHY; RECEPTOR-MEDIATED ENDOCYTOSIS; CELL-PENETRATING PEPTIDES;
   ZNSE NANOCRYSTAL EMITTERS; INDUCED TISSUE FACTOR; VX-2 RABBIT TUMORS
ER

PT J
DE MR spectroscopy; contrast agents; cardiovascular molecular imaging;
   cardiovascular disease
ID CREATINE-KINASE; RESONANCE; MYOCARDIUM; DYSFUNCTION
ER

PT J
DE apoptosis; molecular imaging; cardiovascular disease; annexin A5
ID ACUTE MYOCARDIAL-INFARCTION; CARDIAC ALLOGRAFT-REJECTION; IN-VIVO
   DETECTION; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MEMBRANE PHOSPHOLIPID
   ASYMMETRY; POSITRON-EMISSION-TOMOGRAPHY; RADIOLABELED ANNEXIN-V;
   PROGRAMMED CELL-DEATH; ATHEROSCLEROTIC LESIONS; NONINVASIVE DETECTION
ER

PT J
ID POSITRON-EMISSION-TOMOGRAPHY; DRUG DEVELOPMENT; TRANSLATIONAL RESEARCH;
   GENE-EXPRESSION; BIOLOGICAL PROCESSES; TRANSGENIC ANIMALS; TARGETED
   THERAPY; SYSTEMS BIOLOGY; LIVING SUBJECTS; CANCER
ER

PT J
ER

PT S
DE ultrasound; imaging; nanoparticles; magneto-motive; nanocomposites;
   cellular imaging; magnetic force; contrast agents; molecular imaging
ID CONTRAST AGENT
ER

PT S
DE fluorescence imaging; molecular imaging; LSQR; ART
ID OPTICAL TOMOGRAPHY; EQUATIONS; MEDIA; RATIO
ER

PT J
DE molecular imaging; optical imaging; magnetic resonance imaging (MRI);
   nuclear imaging; arthritis
ID POSITRON-EMISSION-TOMOGRAPHY; RHEUMATOID-ARTHRITIS; ARTICULAR-CARTILAGE;
   DISEASE-ACTIVITY; CONTRAST AGENTS; MODEL; SCINTIGRAPHY; KNEE; TISSUE;
   JOINT
ER

PT J
ER

PT J
DE molecular imaging; molecular guided therapy; nuclear medicine
ID DIFFERENTIATED THYROID-CARCINOMA; NUCLEAR-MEDICINE PROCEDURES;
   RADIOIODINE THERAPY; FDG-PET; RADIATION-EXPOSURE; GRAVES-DISEASE;
   GENE-THERAPY; IN-VIVO; X-RAY; JOURNAL NUKLEARMEDIZIN
ER

PT J
DE PET; SPECT; bioluminescence imaging; molecular imaging; molecular
   sensitivity
ER

PT J
DE positron emission tomography; magnetic resonance imaging; optical
   imaging; inflammation imaging; gene expression imaging
ID POSITRON-EMISSION-TOMOGRAPHY; REPORTER GENE-EXPRESSION; KAPPA-B
   ACTIVATION; IN-VIVO; TRANSGENE EXPRESSION; PSEUDOMONAS-AERUGINOSA; LOBAR
   PNEUMONIA; LIVING ANIMALS; MOUSE MODEL; PULMONARY
ER

PT J
DE transillumination; light scattering; optical imaging; molecular imaging;
   diffusion
ID OPTICAL MAMMOGRAPHY; RECONSTRUCTION; TOMOGRAPHY; ANIMALS; TUMORS; LIGHT
ER

PT J
DE molecular imaging; contrast agents; optical coherence tomography;
   scattering; absorption; nonlinear optics
ID STOKES-RAMAN SCATTERING; TIME-FREQUENCY-DISTRIBUTIONS;
   HIGH-SPECTRAL-RESOLUTION; IN-VIVO; BIOLOGICAL TISSUE; DOPPLER
   TOMOGRAPHY; BLOOD OXYGENATION; HIGH-SENSITIVITY; MULTIPLEX CARS; FLOW
   VELOCITY
ER

PT J
DE molecular imaging; imaging techniques; contrast agents
ID GREEN-FLUORESCENT PROTEIN; DIFFUSE OPTICAL TOMOGRAPHY; REPORTER
   GENE-EXPRESSION; POSITRON-EMISSION-TOMOGRAPHY; TO-NOISE RATIO; IN-VIVO;
   CONTRAST AGENTS; HIGH-RESOLUTION; QUANTUM DOTS; PROJECTION TOMOGRAPHY
ER

PT J
DE preclinical studies; animal models; molecular imaging; ultrasound;
   ultrasound contrast agents
ID CENTRAL-NERVOUS-SYSTEM; TRANSENDOTHELIAL MIGRATION; TUMOR ANGIOGENESIS;
   IN-VIVO; MICROBUBBLES; ADHESION; CELLS; ALPHA-4-INTEGRIN; INFLAMMATION;
   SELECTIN
ER

PT J
ER

PT J
DE magnetic resonance imaging (MRI); molecular imaging; multimodality
   imaging; optical imaging
ID STEM-CELL MIGRATION; OVARIAN TUMOR XENOGRAFTS; VEGF SIGNALING INHIBITOR;
   SINGLE MAMMALIAN-CELLS; IN-VIVO ASSESSMENT; CONTRAST AGENTS; NONINVASIVE
   DETECTION; TAT PEPTIDE; PROSTATE-CANCER; GENE-EXPRESSION
ER

PT J
DE in vivo diagnostics; molecular imaging; magnetic resonance (MR);
   nanoparticles; near IR fluorescence imaging (NIRF); positron emission
   tomography (PET); single photon emission computed tomography (SPECT);
   small-animal imaging (SAI); targeted contrast agents
ID POSITRON-EMISSION-TOMOGRAPHY; IRON-OXIDE PARTICLES; GENE-EXPRESSION;
   TELOMERASE ACTIVITY; REPORTER GENE; CANCER; MICE; APOPTOSIS; THERAPY;
   TUMORS
ER

PT S
ID DIFFUSION TOMOGRAPHY
ER

PT J
ID POSITRON-EMISSION-TOMOGRAPHY; GASTROINTESTINAL STROMAL TUMORS;
   SUPERPARAMAGNETIC IRON-OXIDE; TARGETED CONTRAST AGENT; HIGH-RESOLUTION
   MRI; GENE-EXPRESSION; IN-VIVO; NONINVASIVE DETECTION; TRANSGENE
   EXPRESSION; TRANSFERRIN RECEPTOR
ER

PT J
ER

PT J
DE fluorescence; molecular imaging; fluorescence reflectance imaging;
   fluorescence molecular tomography
ID DIFFUSE OPTICAL TOMOGRAPHY; CONTRAST AGENTS; TURBID MEDIA; HUMAN SKIN;
   MICROSCOPY; PROBES; RECONSTRUCTION; SPECTROSCOPY; BEACONS; CELLS
ER

PT S
DE molecular imaging in cardiology; atherosclerotic plaques; cardiac
   neurotransmission
ER

PT J
ID IN-VIVO
ER

PT J
DE rheumatoid arthritis; molecular markers; molecular imaging; radiological
   diagnostics; fluorescence imaging
ID INFLAMMATION; WRIST
ER

PT J
DE molecular nuclear medicine; imaging; PET; SPECT
ID ANTISENSE; SPECT; PET
ER

PT J
DE molecular imaging; nanotechnology; magnetic resonance imaging
ID INDUCED TISSUE FACTOR; IN-VIVO; GENE-EXPRESSION; CONTRAST AGENT; CAROTID
   ARTERIES; SYSTEM; NANOPARTICLES; VISUALIZATION; TRANSFECTION;
   ENHANCEMENT
ER

PT J
ID POSITRON-EMISSION-TOMOGRAPHY; MAGNETIC-RESONANCE MICROSCOPY; RAY
   COMPUTED-TOMOGRAPHY; DIFFUSE OPTICAL TOMOGRAPHY; IRON-OXIDE PARTICLES;
   TRAFFICKING IN-VIVO; LIVING ANIMALS; TRANSGENE EXPRESSION; TUMOR
   ANGIOGENESIS; NERVOUS-SYSTEM
ER

PT J
DE gene therapy; imaging; nuclear medicine; molecular medicine
ID VIRUS-THYMIDINE KINASE; IN-VIVO; MONOCLONAL-ANTIBODY; RETROVIRAL VECTOR;
   TRANSFECTED GENES; TUMOR-SUPPRESSOR; REPORTER GENE; LUNG-CANCER;
   EXPRESSION; RECEPTOR
ER

PT J
ID RECEPTORS; PEPTIDE
ER

PT J
DE editorials; genes and genetics; magnetic resonance (MR), utilization;
   radionuclide imaging
ID MAGNETIC-RESONANCE MICROSCOPY; POSITRON-EMISSION-TOMOGRAPHY;
   HERPES-SIMPLEX VIRUS; KINASE GENE-TRANSFER; IN-VIVO; P-GLYCOPROTEIN;
   DRUG DISCOVERY; TURBID MEDIA; EXPRESSION; THERAPY
ER

EF